about the group
appellate attorneys
docket reports
oral arguments
news on
30 October 2006

Mayer, Brown, Rowe & Maw advises AstraZeneca and CAT on sale of Humira® royalty stream to Royalty Pharma
Mayer, Brown, Rowe & Maw LLP

30 October 2006 - International law firm Mayer, Brown, Rowe & Maw LLP's Corporate group has acted for AstraZeneca and its subsidiary Cambridge Antibody Technology Limited (CAT) in the disposal by CAT of its Humira® royalty stream to Royalty Pharma for a cash consideration of around $700 million. The sale signed and completed on 25 October.

This was an innovative deal for AstraZeneca and relates to the first product from the UK biotech industry to achieve blockbuster status. Humira® is a drug developed and marketed by Abbott to treat rheumatoid arthritis.

London senior partner Paul Maher and IP partner Sarah Byrt led the Mayer, Brown, Rowe & Maw team, supported by tax partner Peter Steiner, corporate associates Karrie Walsh and Hwei Tan and IP associate Sangeeta Puran. US law support was provided within the London office by Mark Uhrynuk and Paul de Bernier.

Goodwin Procter of Boston advised Royalty Pharma.

For further information:
Paul Maher
+44 (0)20 7782 8815

[ Go Back ]

© 2015. The Mayer Brown Practices. All rights reserved. --  Legal Notices | Attorney Advertising

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the “Mayer Brown Practices”). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. “Mayer Brown” and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.